2024
APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression.
Hase N, Misiak D, Taubert H, Hüttelmaier S, Gekle M, Köhn M#
Mol Oncol. 2024 Aug 26. doi: 10.1002/1878-0261.13721.
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing.
Wedler A, Bley N, Glaß M, Müller S, Rausch A, Lederer M, Urbainski J, Schian L, Obika KB, Simon T, Peters LM, Misiak C, Fuchs T, Köhn M, Jacob R, Gutschner T, Ihling C, Sinz A, Hüttelmaier S.
Nucleic Acids Res. 2024 Apr 24;52(7):3971-3988.
Rbfox1 controls alternative splicing of focal adhesion genes in cardiac muscle cells.
Zorn P, Calvo Sánchez J, Alakhras T, Schreier B, Gekle M, Hüttelmaier S, Köhn M#
J Mol Cell Biol. 2024 Jul 1;16(1):mjae003.
2023
The pro-sequence of parathyroid hormone prevents premature amyloid fibril formation.
Sachan S, Moya CG, Voigt B, Köhn M, Balbach J.
FEBS Lett. 2023 Apr;597(7):995-1006. doi: 10.1002/1873-3468.14587.
2022
Lighting up Nobel Prize-winning studies with protein intrinsic disorder.
Piersimoni L, Abd El Malek M, Bhatia T, Bender J, Brankatschk C, Calvo Sánchez J, Dayhoff GW, Di Ianni A, Figueroa Parra JO, Garcia-Martinez D, Hesselbarth J, Köppen J, Lauth LM, Lippik L, Machner L, Sachan S, Schmidt L, Selle R, Skalidis I, Sorokin O, Ubbiali D, Voigt B, Wedler A, Wei AAJ, Zorn P, Dunker AK, Köhn M#, Sinz A, Uversky VN.
Cell Mol Life Sci. 2022 Jul 26;79(8):449. doi: 10.1007/s00018-022-04468-y.
2021
Small but Mighty-The Emerging Role of snoRNAs in Hematological Malignancies.
Calvo Sánchez J, Köhn M#
Noncoding RNA. 2021 Oct 26;7(4):68. doi: 10.3390/ncrna7040068.
Identification and initial characterization of POLIII-driven transcripts by msRNA-sequencing.
Zorn P, Misiak D, Gekle M, Köhn M#
RNA Biol. 2021 Jan 18:1-11. doi: 10.1080/15476286.2020.1871216.
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration
Cui C, Liu Y, Gerloff D, Rohde C, Pauli C, Köhn M, Misiak D, Oellerich T, Schwartz S, Schmidt LH, Wiewrodt R, Marra A, Hillejan L, Bartel F, Wickenhauser C, Hüttelmaier S, Göllner S, Zhou F, Edemir B, Müller-Tidow C.
Oncogene. 2021 Feb;40(5):909-921. doi: 10.1038/s41388-020-01570-y.
2019
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
Wach S, Taubert H, Weigelt K, Hase N, Köhn M, Misiak D, Hüttelmaier S, Stöhr CG, Kahlmeyer A, Haller F, Vera J, Hartmann A, Wullich B, Lai X.
Cancers (Basel). 2019 Dec 24;12(1):64. doi: 10.3390/cancers12010064.
POLIII-derived non-coding RNAs acting as scaffolds and decoys.
Täuber H, Hüttelmaier S, Köhn M#
J Mol Cell Biol. 2019 Jun 1. pii: mjz049. doi: 10.1093/jmcb/mjz049
2018
HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA.
Tebaldi T*, Zuccotti P*, Peroni D*, Köhn M*, Gasperini L, Potrich V, Bonazza V, Dudnakova T, Rossi A, Sanguinetti G, Conti L, Macchi P, D'Agostino V, Viero G, Tollervey D, Hüttelmaier S, Quattrone A.
Mol Cell. 2018 Jul 19;71(2):256-270.e10. doi: 10.1016/j.molcel.2018.06.032.
2017
Identification of a novel lncRNA induced by the nephrotoxin ochratoxin A and expressed in human renal tumor tissue.
Polovic M, Dittmar S, Hennemeier I, Humpf HU, Seliger B, Fornara P, Theil G, Azinovic P, Nolze A, Köhn M, Schwerdt G, Gekle M.
Cell Mol Life Sci. 2018 Jun;75(12):2241-2256. doi: 10.1007/s00018-017-2731-6.
AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.
Zhou F, Liu Y, Rohde C, Pauli C, Gerloff D, Köhn M, Misiak D, Bäumer N, Cui C, Göllner S, Oellerich T, Serve H, Garcia-Cuellar MP, Slany R, Maciejewski JP, Przychodzen B, Seliger B, Klein HU, Bartenhagen C, Berdel WE, Dugas M, Taketo MM, Farouq D, Schwartz S, Regev A, Hébert J, Sauvageau G, Pabst C, Hüttelmaier S, Müller-Tidow C.
Nat Cell Biol. 2017 Jul;19(7):844-855. doi: 10.1038/ncb3563.
* First Author
# Corresponding Author